Solstice Surpasses 400M TVL as NYSEListed Bullish Joins Its Institutional Allocator Network AEW Double or Nothing 2026 Match Card Streaming Details and Event Strategy for May 24 PayPerView Market Speculates on Timeline for Potential Shift Away from Quarterly Earnings Reports Bessent Anticipates Substantial Disinflation as Warshs Potential Fed Leadership Looms SP 500 Edges Higher as Technology Rally Powers Gains Despite Energy Drag Spotify Soars 13 on AI Music Deal with Universal Music and LongTerm Guidance CTNT Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Management Amidst Revenue Uncertainty Eagle Point Income Company Inc EIC Q4 2025 Earnings Slight EPS Miss but Stock Holds Steady PSQ Holdings Inc PSQH Q1 2026 Earnings Narrower Loss Beats Estimates Yet Stock Declines RFIL Q1 2026 Earnings Strong EPS Beat of 96 Surprises Analysts VECO Q1 2026 Earnings EPS Misses Estimates by Over 40 Shares Edge Lower FMNB Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Slight Stock Dip Ares Dynamic Credit Allocation Fund ARDC Narrows Slightly as Price Stays Within Defined Range Madison Square Garden Entertainment MSGE Holds Steady Amid Narrow Trading Range EVOXW Warrants Hold Steady at 032 Amid Quiet Trading Perpetua Resources PPTA Slips 15 as Stock Consolidates Between Key Support and Resistance Levels IAC Inc IAC Edges Lower as Stock Consolidates Near Support Levels ONGC Q4 Net Profit Surges 46 YoY to Rs 10820 Crore Revenue Up 4 NAT Q4 2025 Earnings EPS Misses Estimates by 56 Stock Declines 235 Grayscale Avalanche Staking ETF GAVA Climbs 175 as Price Approaches Key Resistance VF Corporation VFC Holds Steady Near Support Amidst Mixed Market Signals TMobile US Senior Notes TMUSI Edge Higher Yield Considerations and Key Levels AMETEK Inc AME Edges Higher as Technical Indicators Suggest RangeBound Trading Allot Ltd ALLT Faces Resistance Near 8 After Modest Decline Public Policy Holding Co PPHC Slips 35 as Shares Test Key Support Near 1112 Core Scientific Warrants Surge Over 5 as Bullish Momentum Builds Alnylam Pharmaceuticals ALNY Surges 319 as Biotech Momentum Builds